The current report analyzes the genetic testing market. It discusses the drivers and challenges prevailing in the genetic testing market. It presents the competitive conditions prevailing in the market, along with the profiles of major players.

1. View Report Details
Genetic Testing Market Report
--------------------------------
2012

2. View Report Details
Executive Summary
Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic
testing market segment represents the highest growth opportunity compared to other segments within the molecular
diagnostics market. The growth of the market is backed by increasing prevalence of genetic diseases, aging population, and
rising awareness. Vast application areas including newborn screening, prenatal and pre implantation testing is also expected
to add to the future growth of the market.
The technological advancements of genetic testing are expected to break new grounds in the field of personalized medicine
as genetic testing helps not only in the better diagnosis of genetic diseases but also aids in selecting the best medication
depending on the DNA structure of the patient to ensure superior drug response.
Direct to customer (DTC) genetic testing is one of the major trends in the market, which is expected to bring positive changes
in the popularity of genetic testing. However, the quality, accuracy, and proper interpretation of test results of DTC genetic
testing continue to challenge the future growth of the market. Furthermore, the risk of genetic discrimination and psychological
consequences of genetic testing are also expected to hinder the growth of the market in the coming years.
The current report analyzes the genetic testing market. It discusses the drivers and challenges prevailing in the genetic
testing market. It presents the competitive conditions prevailing in the market, along with the profiles of major players.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future
growth of the global genetic testing market. We employed various significant variables that have an impact on this industry
and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the
regression model, the relationship between several independent or predictor variables and the dependent variable was
analyzed using standard SPSS output, including charts, tables and tests.

3. Strong growth of global genetic testing market on the back of growing prevalence
of cancer and increasing availability of genetic tests…
Global Genetic Testing Market  In 2007, the market for genetic testing was valued at ……………billion
and it registered a CAGR of ……% to reach US$......billion in 2011.
Currently, genetic testing……………………………………………….
The improving ………………..scenario in the ……………………………
……………………………………………………… is also adding to the
growth of the market……………………………………
 Gene therapy involves ………………. Gene therapy can be used to
US$ Billion
……………. There were around ………….gene therapy clinical trials in
progress during 2011 globally, …… diseases accounted for about …%
………………………………………………………………………………..
………………………………………………………….
 The large-scale ……initiatives, coupled with …….. due to ……. have
led to ….. in the availability of ………... Genetic testing was used for
approximately …… diseases in ……………………………..................
2007 2008 2009 2010 2011 which recorded a CAGR of ….% to reach …… diseases in 2010. New
technologies, ………………………………………………………………
Worldwide Gene Therapy Clinical Trials by Disease
Worldwide Number of Diseases with Availability of Genetic
No. of Diseases
Other Diseases Ocular Diseases
Neurological Diseases Monogenic Diseases
Inflammatory Diseases Infectious Diseases 2005 2006 2007 2008 2009 2010 2011E
Healthy Volunteers Gene Marking
Cardiovascular Diseases Cancer Diseases

4. Significant growth opportunity of genetic testing market supported by the
favorable demographic trends and technological advances…
Growth Opportunity of European Genetic Testing Market
 The ……………………segment within the European
genetic testing market is regarded more ……………. as
compared to the ……………….. segments, majorly due to
the ………………………………… tests. It is expected that
%
the Y-O-Y growth rate of the market will increase to
………………..% in 2015 as compared to ………………%
in 2011. However, the …………………… segment is
expected to maintain …………….. Y-O-Y growth in the
coming years and reach ……..% by 2015 from ………….%
in 2011. The yearly growth rate of ……………. segment
2011 2012E 2013E 2014E 2015E
……………% in 2015.
Predictive Testing Diagnostic Testing Relationship Testing
 Pharmacogenetics is generally regarded as ………….……
……………………………….. gives rise to ………………
………………... In 2005, ……………………………..million
Projected Number of Pharmacogenetic Tests in the US Pharmacogenetic tests were performed in the US, which
increased at a CAGR of ………………………………% to
reach …………………………………………………….It is
expected that the overall number of Pharmacogenetic
tests will reach ……………………. million by 2013,
recording a CAGR of ……………% during 2010-2013.
Million
2005 2006 2007 2008 2009 2010 2011E 2012E 2013E

5. The worldwide genetic testing market represents strong growth opportunity in
coming years majorly due aging population and occurrence of genetic diseases…
Worldwide Genetic Testing Market Forecast
US$ Billion
2011A 2012E 2013E 2014E 2015E
• The global genetic testing market has witnessed ………………..growth in the past few years, which is projected to
……………………………………..in the coming years. In 2011, the global genetic market was valued at approximately
US$....................... billion, which is expected to grow up to US$.................. billion by the end of 2015. The market is estimated to
grow at a CAGR of …………………% during 2011-15. The major factors to drive this growth in near future include ………………..,
growing …………………….., and increasing prevalence of …………………….and ………………..

6. View Report Details
Table of Contents List of Charts
1. Genetic Testing: An Introduction Classification of Molecular Diagnostics
Global Molecular Diagnostics Market, 2005-2015E
1.1 Types of Genetic Testing Global Molecular Diagnostic Market by Region, 2010
1.2 Pros and Cons of Genetic Testing Global Genetic Testing Market, 2007-2011
1.3 Insurance Coverage of Genetic Testing Worldwide Number of Diseases with Availability of Genetic Testing,
1.4 Cost and Time Factor Associated to Genetic Testing 2005-2011E
1.5 Procedure of Genetic Testing Worldwide Gene Therapy Clinical Trials by Disease, 2011
1.6 Risks and Limitations of Genetic Testing Worldwide Gene Therapy Clinical Trials by Gene, 2011
Gene Therapy Clinical Trials by Country, 2011
2. Global Genetic Testing Market Gene Therapy Clinical Trials by Phase, 2011
Worldwide Market for Potential Cancer Clinical Trials, 2012E-2015E
Market Value Global DNA and Gene Chip Market, 2010A-2015E
Market Segmentation Global DNA Sequencing Market, 2014E
Regional Breakdown Global Projected Addressable Market for Genomes, 2011E-2015E
Other Market Statistics European Genetic Testing Market by Segments, 2011
Growth Opportunity of European Genetic Testing Market, 2011-2015E
2.1 Genetic Testing Market in Europe Projected Number of Pharmacogenetic Tests in the US, 2003-2013E
Growth of Global Aging Population, 2005-2012E
Market Overview Global Healthcare Spending, 2005-2015E
Market Segmentation New Cases of Cancer Worldwide, 2005-2010
Growth Opportunity Market Share of Major Players in the Global Molecular Diagnostics
Market, 2010
2.2 Pharmacogenetics Market in the US Global Life Science Industry, 2011E
Market Share of Major Players in the Gene Sequencing Market, 2011
3. Key Trends Market Share of Major Players in the Microarray Market, 2010
Share of Sales by Reportable Segments, 2011
3.1 Strong Growth Opportunity for Carrier Genetic testing Net Sales and Net Income of Abbott, 2007-2011
3.2 Proactive Healthcare through DTC Genetic Testing Share of Net Sales by Geographic Segments, 2011
3.3 Legislations to Fight Genetic Discrimination in the US Net Sales and Net Income of Qiagen, 2007-2011
4. Growth Drivers
4.1 Increasing Knowledge about Genetic Testing
4.2 Rising Ageing Population
4.3 Growing Healthcare Expenditure
4.4 Increasing Prevalence of Cancer

7. View Report Details
5. Significant Developments List of Charts
5.1 Gene Scan of Alzheimer's Families Identifies Four New Share of Sales by Segments, 2011
Suspect Genes Total Sales of Roche, 2008-2011
5.2 WARFARIN Study Launched by Iverson Genetic Diagnostics Quest Diagnostic’s Revenues by Business Segments, 2011
5.3 Genzyme Introduces New Genetic Test for Lung Cancers Quest Diagnostic’s Revenues and Net Income, 2006-2011
5.4 Clinical Data Launches Genetic Test for HCM Figure 9.1: worldwide Genetic Testing Market, 2011A-2015E
6. Challenges List of Tables
6.1 Genetic Discrimination Dependent & Independent Variables, 2007–2011
6.2 Psychological Consequences of Genetic Testing Correlation Matrix
6.3 Quality Concerns Related to Biochemical Genetic Testing Model Summary – Coefficient of Determination
Regression Coefficients Output
7. Genetic Testing - Competitive Landscape
Competitive Overview
Market Share
8. Company Profile
8.1 Abbott
Business Description
Key Financials
Business Strategies
Business Diversification strategy
R&D Strategy
8.2 Qiagen NV.
Business Description
Key Financials
Business Strategies
Addressing Unmet Market Needs
Sales and Marketing Strategy

8. View Report Details
8.3 Roche
Business Description
Key Financials
Business Strategies
Delivering Personalized Healthcare
Creating Sustainable Value
Fostering Innovation
8.4 Quest Diagnostics
Business Description
Key Financials
Business Strategies
Continuously Drive Six Sigma Quality
Leveraging Assets & Capabilities
9. Market Outlook
9.1 Market Forecast
9.2 Forecast Methodology
9.2.1 Dependent and Independent variables
9.2.2 Correlation Analysis
9.2.3 Regression Analysis

9. View Report Details
Contact Us:
These are abridged and sanitized sample pages from the comprehensive report on the “Global Genetic Testing Market
Report”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
Vikas Gupta T. +91-120-4130959
BD Manager C: +91-9811715635
vikas@konceptanalytics.com
www.konceptanalytics.com